Insmed Incorporated

May 9, 2016May 9, 2016

Insmed Incorporated to Present Data on Liposomal Technology To Treat PAH, IPF at 2016 American Thoracic Society Meeting

Insmed Incorporated recently announced that it will present three ARIKAYCE™-related abstracts and one treprostinil prodrug abstract at the American Thoracic Society (ATS) 2016 International Conference in San Francisco, May 13-18. ARIKAYCE™ ... Read more

October 20, 2015November 9, 2015

The Balancing Act on Lifetime to Feature NTM Lung Disease, Sponsored By Insmed Incorporated

COPD, News

Bridgewater, New Jersey based Insmed Incorporated, a global biopharmaceutical company with a research and development focus on centered on the needs of patients battling serious rare diseases of high unmet ... Read more

October 15, 2015October 15, 2015

INSMED Launches Comprehensive Educational Campaign to Raise NTM Lung Disease Awareness

News

Bridgewater, New Jersey based global biopharmaceutical company Insmed Incorporated has announced the launch of NTM Facts, an educational campaign designed to raise awareness of nontuberculous mycobacterial (NTM) lung disease. NTM ... Read more

May 18, 2015November 5, 2015

Insmed to Present on Rare Lung Disease Therapies at ATS Conference

News, Pulmonary Hypertension

Insmed Incorporated is presenting data on their therapies for rare pulmonary conditions at the American Thoracic Society‘s (ATS) 2015 International Conference, which is currently underway and will wrap up on May 20th in Denver. ... Read more

September 4, 2014

Insmed Presents Novel Inhalation Technologies for Lung Diseases, Infections at European Respiratory Society’s International Congress 2014

News

Insmed Incorporated‘s novel inhalation technologies for the treatment of orphan pulmonary diseases will be presented to the medical community at the European Respiratory Society’s International Congress 2014, which will take ... Read more